Cardiac safety of trastuzumab as adjuvant treatment for Japanese patients with early breast cancer

被引：0
|
作者：
Mikiya Ishihara
Hirofumi Mukai
Shunji Nagai
Toru Mukohara
机构：
[1] National Cancer Center Hospital East,Division of Oncology/Hematology
来源：
International Journal of Clinical Oncology | 2009年 / 14卷
关键词：
Adjuvant drug therapy; Breast cancer; Cardiac safety; Japanese patients; Trastuzumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：431 / 435
页数：4
相关论文
共 50 条
  • [1] Cardiac safety of trastuzumab as adjuvant treatment for Japanese patients with early breast cancer
    Ishihara, Mikiya
    Mukai, Hirofumi
    Nagai, Shunji
    Mukohara, Toru
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (05) : 431 - 435
  • [2] The cardiac safety of trastuzumab in the treatment of breast cancer
    Chien, A. Jo
    Rugo, Hope S.
    EXPERT OPINION ON DRUG SAFETY, 2010, 9 (02) : 335 - 346
  • [3] Adjuvant Trastuzumab Treatment without Adjuvant Chemotherapy in Early Breast Cancer
    Dall, P.
    Koch, T.
    Lenzen, G.
    Kuhn, T.
    Hielscher, C.
    Reichert, D.
    Maasberg, M.
    Ehscheidt, P.
    Eustermann, H.
    Fischer, G.
    CANCER RESEARCH, 2011, 71
  • [4] TRASTUZUMAB AS ADJUVANT THERAPY IN HER2+ EARLY BREAST CANCER - CARDIAC SAFETY ANALYSIS
    Ferreira, M.
    Soares, R. H. V. S.
    Godinho, J.
    Shvets, Y.
    Couto, N.
    Afonso, N.
    Pereira, D.
    Rodrigues, H.
    ANNALS OF ONCOLOGY, 2010, 21 : 90 - 90
  • [5] Adjuvant trastuzumab in early breast cancer
    Mariani, G.
    Gianni, L.
    ANNALS OF ONCOLOGY, 2006, 17 : X54 - X58
  • [6] Early cardiotoxicity after adjuvant concomitant treatment with radiotherapy and trastuzumab in patients with breast cancer
    Marinko, Tanja
    Borstnar, Simona
    Blagus, Rok
    Dolenc, Jure
    Bilban-Jakopin, Cvetka
    RADIOLOGY AND ONCOLOGY, 2018, 52 (02) : 204 - 212
  • [7] Trastuzumab in the adjuvant treatment of breast cancer
    Svetlovska, D.
    Mardiak, J.
    Kristova, V
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2007, 108 (02): : 100 - 103
  • [8] Safety of adjuvant trastuzumab (T) in elderly patients with breast cancer.
    Militello, L.
    Carli, P.
    Spazzapan, S.
    Lestuzzi, C.
    Miolo, G.
    Scalone, S.
    Veronesi, A.
    Crivellari, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [9] Cardiac safety guidelines for the adjuvant use of trastuzumab (Herceptin®) in HER2-positive early breast cancer
    Ewer, M. S.
    Perez, E. A.
    Baselga, J.
    Bell, R.
    Brutsaert, D.
    Marty, M.
    Pienkowski, T.
    Suter, T. M.
    BREAST, 2007, 16 : S63 - S63
  • [10] Cardiac safety of docetaxel/cyclophosphamide/trastuzumab (DCH) as adjuvant therapy for HER-2 (+) early stage breast cancer
    Mato, A.
    Cappa, M.
    Fox, K.
    Policarpo, G.
    Cohen, J.
    Wall, H.
    Rossi, S.
    Mintzer, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345